| Bryan Grossman, OD | |
|
483 W Seed Farm Rd, Sacaton, AZ 85147-5000 | |
| (602) 271-7960 | |
| Not Available |
| Full Name | Bryan Grossman |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 3 Years |
| Location | 483 W Seed Farm Rd, Sacaton, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801467790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 002505 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmic Surgeons And Physicians Ltd | 1052309374 | 7 |
News Archive
Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.
Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency.
Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 8 days ago
| Provider Name | Ophthalmic Surgeons & Physicians Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689648925 PECOS PAC ID: 1052309374 Enrollment ID: O20040505000412 |
News Archive
Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.
Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency.
Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Grossman, OD Po Box 38, Sacaton, AZ 85147-1255 Ph: (602) 528-1200 | Bryan Grossman, OD 483 W Seed Farm Rd, Sacaton, AZ 85147-5000 Ph: (602) 271-7960 |
News Archive
Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.
Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency.
Features of the blast phase, such as blast cell morphology and accompanying cytogenetic changes, vary between chronic myeloid leukaemia patients who received tyrosine kinase inhibitor therapy and those treated in the pre-TKI era, research shows.
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale, US from 6 - 10 May. The ARVO meeting is the world's largest gathering of international eye and vision researchers.
› Verified 8 days ago
Rachel Ressler, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 520-562-3321 | |
Aaron Todd Solen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-528-1200 Fax: 602-528-1255 | |
Dr. Sydney Mae Gross, OD Optometrist Medicare: Medicare Enrolled Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-271-7960 | |
Betty Ng, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 520-562-3321 | |
Cristina Acevedo, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-271-7960 Fax: 602-271-7872 | |
Mai Chia Lee, OD Optometrist Medicare: Medicare Enrolled Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-271-7960 | |
Shannon Yvonne Borrego, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 483 W. Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-528-1200 |